Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bfed88e0fc39231cf9056f4fc4d683f92> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bfed88e0fc39231cf9056f4fc4d683f92 NCIT_P378 "NCI" @default.
- Bfed88e0fc39231cf9056f4fc4d683f92 type Axiom @default.
- Bfed88e0fc39231cf9056f4fc4d683f92 annotatedProperty IAO_0000115 @default.
- Bfed88e0fc39231cf9056f4fc4d683f92 annotatedSource NCIT_C185864 @default.
- Bfed88e0fc39231cf9056f4fc4d683f92 annotatedTarget "An orally bioavailable, irriversible inhibitor of menin, an essential co-factor of oncogenic menin-mixed lineage leukemia (MLL; myeloid/lymphoid leukemia; KMT2A) fusion proteins, with potential antineoplastic activity. Upon oral administration, menin inhibitor BMF-219 specifically targets and binds to menin, thereby preventing the interaction between the two proteins menin and MLL and the formation of the menin-MLL complex. This reduces the expression of downstream target genes, such as MYC and Bcl2, and results in an inhibition of the proliferation of MLL-rearranged tumor cells. Menin, an essential transcriptional regulator, plays a key role in oncogenic signaling in cancers driven by oncogenic MLL-fusions." @default.